Matrix metalloproteinases (MMP), EMMPRIN (extracellular matrix metalloproteinase inducer) and mitogen-activated protein kinases (MAPK): Co-expression in metastatic serous ovarian carcinoma

Author： Davidson Ben   Givant-Horwitz Vered   Lazarovici Philip   Risberg Björn   Nesland Jahn   Trope Claes   Schaefer Erik   Reich Reuven  

Publisher： Springer Publishing Company

ISSN： 0262-0898

Source： Clinical and Experimental Metastasis, Vol.20, Iss.7, 2003-11, pp. : 621-631

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma

By Davidson Ben   Goldberg Iris   Berner Aasmund   Kristensen Gunnar   Reich Reuven  

Clinical and Experimental Metastasis, Vol. 20, Iss. 2, 2003-03 ,pp. : 161-169

Springer Publishing Company

Access to resources Recommend Favorite

Mitogen-activated protein kinases (MAPK) as predictors of clinical outcome in serous ovarian carcinoma in effusions

By Givant-Horwitz V.   Davidson B.   Lazarovici P.   Schaefer E.   Nesland J.M.   Trope C.G.   Reich R.  

Gynecologic Oncology, Vol. 91, Iss. 1, 2003-10 ,pp. : 160-172

Elsevier

Access to resources Recommend Favorite

Mitogen-activated protein kinases (MAPK) as predictors of clinical outcome in serous ovarian carcinoma in effusions

By Miller Brigitte  

The Women's Oncology Review, Vol. 4, Iss. 1, 2004-01 ,pp. : 27-28

Informa Healthcare

Access to resources Recommend Favorite

A novel functional site of extracellular matrix metalloproteinase inducer (EMMPRIN) that limits the migration of human uterine cervical carcinoma cells

By Sato Takashi   Watanabe Mami   Hashimoto Kei   Ota Tomoko   Akimoto Noriko   Imada Keisuke   Nomizu Motoyoshi   Ito Akira  

International Journal of Oncology, Vol. 40, Iss. 1, 2012-01 ,pp. : 236-242

Spandidos Publications

Access to resources Recommend Favorite

Expression and clinical significance of extracellular matrix metalloproteinase inducer, EMMPRIN/CD147, in human osteosarcoma

By          

Oncology Letters, Vol. 5, Iss. 1, 2013-01 ,pp. : 201-207

Spandidos Publications

Access to resources Recommend Favorite